aggression 发表于 2025-3-21 17:44:58
书目名称Antimicrobial Prophylaxis in Urology with special reference to the new Quinolones影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0158609<br><br> <br><br>书目名称Antimicrobial Prophylaxis in Urology with special reference to the new Quinolones影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0158609<br><br> <br><br>书目名称Antimicrobial Prophylaxis in Urology with special reference to the new Quinolones网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0158609<br><br> <br><br>书目名称Antimicrobial Prophylaxis in Urology with special reference to the new Quinolones网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0158609<br><br> <br><br>书目名称Antimicrobial Prophylaxis in Urology with special reference to the new Quinolones被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0158609<br><br> <br><br>书目名称Antimicrobial Prophylaxis in Urology with special reference to the new Quinolones被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0158609<br><br> <br><br>书目名称Antimicrobial Prophylaxis in Urology with special reference to the new Quinolones年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0158609<br><br> <br><br>书目名称Antimicrobial Prophylaxis in Urology with special reference to the new Quinolones年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0158609<br><br> <br><br>书目名称Antimicrobial Prophylaxis in Urology with special reference to the new Quinolones读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0158609<br><br> <br><br>书目名称Antimicrobial Prophylaxis in Urology with special reference to the new Quinolones读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0158609<br><br> <br><br>abreast 发表于 2025-3-22 00:01:10
http://reply.papertrans.cn/16/1587/158609/158609_2.pngBUST 发表于 2025-3-22 03:09:59
http://reply.papertrans.cn/16/1587/158609/158609_3.png过滤 发表于 2025-3-22 06:22:15
http://reply.papertrans.cn/16/1587/158609/158609_4.png健谈的人 发表于 2025-3-22 10:27:48
Springer Series in Solid-State Sciencesightly affected by canine prostatic secretion, human prostatic tissue extract, and human urine. Clinical trials with Oeroxacin appear justified for chronic bacterial prostatitis and urinary tract infection,Parallel 发表于 2025-3-22 16:38:59
https://doi.org/10.1007/978-1-4684-3497-2groups, respectively, with no significant difference between groups. This suggests that 250 mg of ciprofloxacin twice daily is sufficient for the treatment of urinary tract infection. All three dosage regimens were well tolerated.镀金 发表于 2025-3-22 17:57:17
http://reply.papertrans.cn/16/1587/158609/158609_7.png和音 发表于 2025-3-22 22:54:14
In Vitro Studiesobial spectrum against most uropathogens and some are active against Pseudomonas aeruginosa, Staphylococcus aureus, Mycoplasma and Chlamydia trachomatis (Hooper and Wolfson, 1991; Nielsen and Madsen, 1989). Moreover, the quinolone MIC against many of these bacteria is very low (see Table 3 and section 2.4.1).依法逮捕 发表于 2025-3-23 03:20:49
Human Studies and Review of the Literaturephylaxis usually not necessary. In clean-contaminated procedures and contaminated procedures, single-dose and short-time (3–5 days) prophylaxis, respectively, should suffice. Dirty wounds require antimicrobial prophylaxis, followed by prolonged therapeutic antimicrobial administration.战役 发表于 2025-3-23 07:12:25
Fleroxacin (Ro 23-6240) Distribution in Canine Prostatic Tissue and Fluidsightly affected by canine prostatic secretion, human prostatic tissue extract, and human urine. Clinical trials with Oeroxacin appear justified for chronic bacterial prostatitis and urinary tract infection,